Thursday, October 29, 2020

Bone Therapeutics and Catalent sign agreements to streamline production of the allogeneic cell ...

... the transaction, the SCTS manufacturing infrastructure and production operating teams will become part of Catalent's Cell & Gene Therapy division.
http://dlvr.it/RkYcVD
-

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...